Zahra Talebi

机构：The Ohio State University · ORCID：0000-0001-9166-5160

发表论文 89 篇 · 总被引 474 次 · h-index 12

代表论文

First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies (2025 · Clinical Cancer Research · 被引 16)
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma (2025 · Clinical Cancer Research · 被引 9)
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations (2025 · Frontiers in Hematology · 被引 2)
A Cardiac-Specific Humanized Mouse Model to Evaluate the Disposition of OCT3 Substrates (Abstract ID: 232616) (2026 · Journal of Pharmacology and Experimental Therapeutics)
Supplementary Figure 2 from Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen (2025)
Supplementary Figure 1 from Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen (2025)